English
Take Solutions Q2 Results
- BSE: 532890
- NSE: TAKE
- ISIN: INE142I01023
- Sector: Biotechnology & Drugs
BSE
41.69
-1.23 (-2.87%)
-1.23 (-2.87%)Volume1.88 L
Updated: Fri 16 Jan, 2026 | 15:29:55
NSE
41.64-1.35 (-3.14%)
-1.35 (-3.14%)Volume1.70 M
Updated: Fri 16 Jan, 2026 | 15:51:01
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹0.00 Cr.(NA%)
- Operating Profit₹-0.30 Cr.(NA%)
- Profit After Tax₹-0.63 Cr.(NA%)
- Operating MarginNA%(NA%)
Note: Comparison is on YoY basis
Quarterly - Take Solutions Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.30 | 0.78 | -61.98% | -0.58 | 0.00% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.01 | -81.82% |
| Operating Income | -0.30 | -0.78 | -61.98% | 0.58 | 0.00% |
| Net Income | 6.29 | -0.91 | 0.00% | -1.58 | 0.00% |
| Other Operating Expenses Total | 0.16 | 0.64 | -75.39% | -0.83 | 0.00% |
| Net Income Before Taxes | -0.47 | -0.91 | -48.57% | 0.08 | 0.00% |
| Total Revenue | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% |
| Selling/ General/ Admin Expenses Total | 0.14 | 0.14 | 0.00% | 0.24 | -42.62% |
| Diluted Normalized EPS | -0.04 | -0.06 | -28.45% | 0.01 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.